SCHEMBL23739718

SCHEMBL23739718

O=CCCC(C=O)N1Cc2c(OCCCC(=O)N3CCN(c4cccc(Cl)c4Cl)CC3)cccc2C1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADAMTS5 Q9UNA0 1/20 0.39
▸ DRD2 P14416 14/20 0.39
▸ DRD3 P35462 8/20 0.39
▸ DRD4 P21917 4/20 0.39
▸ OPRM1 P35372 1/20 0.39
▸ LMNA P02545 3/20 0.38
▸ MAPT P10636 3/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ HTT P42858 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ HTR2A P28223 6/20 0.38
▸ HTR1A P08908 5/20 0.38
▸ TSHR P16473 3/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ HPGD P15428 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23739437 0.90 DRD2 (0.42) ADAMTS5DRD2DRD3DRD4OPRM1
SCHEMBL23739663 0.87 MAPT (0.48) LMNAMAPTKDM4EALDH1A1HTT
SCHEMBL23739841 0.79 MAPT (0.53) LMNAMAPTALDH1A1HTTNPSR1
SCHEMBL23739743 0.78 HTR2A (0.33) LMNAMAPTALDH1A1HTTNPSR1
SCHEMBL23739539 0.77 DRD2 (0.43) DRD2DRD3DRD4HTR2AHTR1A
SCHEMBL23739525 0.77 DRD2 (0.52) DRD2DRD3DRD4HTR2AHTR1A
SCHEMBL23739650 0.77 DRD2 (0.40) DRD2DRD3DRD4HTR2AHTR1A
SCHEMBL23739567 0.77 DRD2 (0.55) DRD2DRD3DRD4HTR2AHTR1A
SCHEMBL23739489 0.76 NPC1 (0.43) LMNAMAPTKDM4EALDH1A1HTT
SCHEMBL23739454 0.75 DRD2 (0.52) DRD2DRD3DRD4HTR2AHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3862348-A1 ISOINDOLINE COMPOUND, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2021-08-11 — — EP disclosed
Send feedback